PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:PHN • IT0005274094
63.1 EUR
+0.4 (+0.64%)
Last: Jan 30, 2026, 07:00 PM
PHN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 14 industry peers in the Personal Care Products industry. PHN gets an excellent profitability rating and is at the same time showing great financial health properties. PHN is quite expensive at the moment. It does show a decent growth rate. These ratings could make PHN a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- PHN had positive earnings in the past year.
- PHN had a positive operating cash flow in the past year.
- PHN had positive earnings in each of the past 5 years.
- In the past 5 years PHN always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 20.17%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 36.55%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- PHN has a better Return On Invested Capital (25.72%) than 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for PHN is significantly above the industry average of 11.81%.
- The 3 year average ROIC (17.21%) for PHN is below the current ROIC(25.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.17% | ||
| ROE | 36.55% | ||
| ROIC | 25.72% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
- The Profit Margin of PHN (13.39%) is better than 78.57% of its industry peers.
- PHN's Profit Margin has declined in the last couple of years.
- PHN has a Operating Margin of 21.79%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
- In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
- Looking at the Gross Margin, with a value of 97.13%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.79% | ||
| PM (TTM) | 13.39% | ||
| GM | 97.13% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
- PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- PHN has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for PHN has been reduced compared to 5 years ago.
- PHN has a better debt/assets ratio than last year.
2.2 Solvency
- PHN has an Altman-Z score of 10.61. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of PHN (10.61) is better than 100.00% of its industry peers.
- The Debt to FCF ratio of PHN is 2.01, which is a good value as it means it would take PHN, 2.01 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of PHN (2.01) is better than 71.43% of its industry peers.
- PHN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
- PHN has a Debt to Equity ratio of 0.24. This is in the better half of the industry: PHN outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | 2.01 | ||
| Altman-Z | 10.61 |
ROIC/WACC3.23
WACC7.97%
2.3 Liquidity
- A Current Ratio of 2.19 indicates that PHN has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.19, PHN belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
- PHN has a Quick Ratio of 1.86. This is a normal value and indicates that PHN is financially healthy and should not expect problems in meeting its short term obligations.
- PHN has a better Quick ratio (1.86) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.86 |
3. Growth
3.1 Past
- PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.84%, which is quite good.
- PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
- The Revenue has grown by 14.35% in the past year. This is quite good.
- Measured over the past years, PHN shows a quite strong growth in Revenue. The Revenue has been growing by 16.59% on average per year.
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%
3.2 Future
- PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.13% yearly.
- Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 13.74% on average per year.
EPS Next Y6.25%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
EPS Next 5YN/A
Revenue Next Year14.8%
Revenue Next 2Y14.39%
Revenue Next 3Y14.28%
Revenue Next 5Y13.74%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 25.14 indicates a quite expensive valuation of PHN.
- Based on the Price/Earnings ratio, PHN is valued a bit cheaper than 64.29% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. PHN is around the same levels.
- PHN is valuated quite expensively with a Price/Forward Earnings ratio of 25.84.
- Based on the Price/Forward Earnings ratio, PHN is valued a bit more expensive than 64.29% of the companies in the same industry.
- PHN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.14 | ||
| Fwd PE | 25.84 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHN indicates a slightly more expensive valuation: PHN is more expensive than 64.29% of the companies listed in the same industry.
- PHN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHN is more expensive than 78.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.6 | ||
| EV/EBITDA | 14.05 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- PHN has an outstanding profitability rating, which may justify a higher PE ratio.
- PHN's earnings are expected to grow with 15.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.02
PEG (5Y)1.72
EPS Next 2Y13.31%
EPS Next 3Y15.13%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.59%, PHN has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 2.05, PHN has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.83, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
5.2 History
- On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 39.70% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
- The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.7%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
Can you provide the valuation status for PHARMANUTRA SPA?
ChartMill assigns a valuation rating of 2 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.
What is the profitability of PHN stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
How financially healthy is PHARMANUTRA SPA?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
Is the dividend of PHARMANUTRA SPA sustainable?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 5 / 10 and the dividend payout ratio is 39.7%.